{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T21:05:26Z","timestamp":1779829526826,"version":"3.53.1"},"reference-count":24,"publisher":"Begell House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Immunol"],"published-print":{"date-parts":[[2026]]},"abstract":"<p>Oral squamous cell carcinoma (OSCC) begins with pre-existing oral potential malignant diseases (OP-MDs), among which oral leukoplakia (OL) is the most common precancerous lesion. This study systematically explored the mechanism of N6-methyladenosine (m6A) RNA methylation in the occurrence and development of OSCC by integrating bioinformatics analysis and experimental verification. Based on the analysis of the GSE85195 dataset, we identified the key differentially expressed genes (DEGs) and m6A regulatory factors in the progression from OL to OSCC. Functional enrichment analysis revealed that these genes were significantly enriched in the extracellular matrix (ECM) signaling pathway. By constructing a protein-protein interaction network, we identified &lt;i&gt;THBS1&lt;\/i&gt; as the core hub gene, and survival analysis revealed that the high expression of THBS1 was associated with a poor prognosis of OSCC patients. Bioinformatics analysis found that IGF2BP2 could regulate the expression of THBS1 through m6A. &lt;i&gt;In vitro&lt;\/i&gt; assays indicated that IGF2BP2 can regulate the expression of THBS1, and knockdown of IGF2BP2 can significantly inhibit the proliferation, migration, and invasion abilities of OSCC cells. Further analysis revealed that the risk score based on IGF2BP2, THBS1, and tumor stage was closely associated with tumor immune microenvironment characteristics. These evidences not only reveal a potential new mechanism by which m6A modification may mediate the IGF2BP2-THBS1 axis to promote the progression of OSCC, but also provide a new theoretical basis for understanding the remodeling of the immune microenvironment of OSCC.<\/p>","DOI":"10.1615\/critrevimmunol.2026061135","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:43:10Z","timestamp":1771954990000},"page":"45-58","source":"Crossref","is-referenced-by-count":0,"title":["Knockdown of IGF2BP2 Inhibits THBS1 in Regulating the Progression of Oral Squamous Cell Carcinoma: An Integrative Analysis"],"prefix":"10.1615","volume":"46","author":[{"given":"Ying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ford PJ, Rich AM. Tobacco use and oral health. Addiction. 2021;116:3531-\u0080\u009340.","DOI":"10.1111\/add.15513"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Warnakulasuriya S. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550.","DOI":"10.1016\/j.oraloncology.2019.104550"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, Virgilio AD, Maio PD, Spriano G, L\u00f3pez SP, Shanti RM. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42:539-\u0080\u009355.","DOI":"10.1002\/hed.26006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Xu X, Yu Y, Zong K, Lv P, Gu Y. Upregulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K\/Akt signaling pathway. J Exp Clin Cancer Res. 2019;38:497.","DOI":"10.1186\/s13046-019-1470-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Xia T, Dai XY, Sang MY, Zhang X, Xu F, Wu J, Shi L, Wei JF, Ding Q. IGF2BP2 drives cell cycle progression in triple-negative breast cancer by recruiting EIF4A1 to promote the m6A-modified CDK6 translation initiation process. Adv Sci. 2024;11:e2305142.","DOI":"10.1002\/advs.202305142"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Lin CW, Yang WE, Su CW, Lu HJ, Su SC, Yang SF. IGF2BP2 promotes cell invasion and epithelial-mesenchymal transition through Src-mediated upregulation of EREG in oral cancer. Int J Biol Sci. 2024;20:818-\u0080\u009330.","DOI":"10.7150\/ijbs.91786"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A. NCBI GEO: Archive for functional genomics data sets-\u0080\u0094update. Nucleic Acids Res. 2013;41:D991-\u0080\u00935.","DOI":"10.1093\/nar\/gks1193"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Rivera CG, Vakil R, Bader JS. NeMo: Network Module identification in Cytoscape. BMC Bioinform. 2010; 11(Suppl 1):S61.","DOI":"10.1186\/1471-2105-11-S1-S61"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA. The DAVID gene functional classification tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8:R183.","DOI":"10.1186\/gb-2007-8-9-r183"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: Prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44:e91.","DOI":"10.1093\/nar\/gkw104"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Wang W, He Y, Wu L, Zhai LL, Chen LJ, Yao LC, Yu KH, Tang ZG. N(6) -methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion. Cancer Med. 2023;12:3731-\u0080\u009343.","DOI":"10.1002\/cam4.5054"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Uhlen M, Zhang C, Lee S, Sj\u00f6stedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu ZT, Edfors F, Sanli K, Feilitzen KV, Oksvold P, Lundberg E, Hober S, Nilsson P, Mattsson J, Schwenk JM, Brunnstr\u00f6m H, Glimelius B, Sj\u00f6blom T, Edqvist PH, Djureinovic D, Micke P, Lindskog C, Mardinoglu A, Ponten F. A pathology atlas of the human cancer transcriptome. Science. 2017;357(6352): eaan2507.","DOI":"10.1126\/science.aan2507"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Divi V, Chen MM, Nussenbaum B, Rhoads KF, Sirjani DB, Holsinger FC, Shah JL, Hara W. Lymph node count from neck dissection predicts mortality in head and neck cancer. J Clin Oncol. 2016;34:3892-\u0080\u00937.","DOI":"10.1200\/JCO.2016.67.3863"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang Z, Pu JJ, Zhong J, Khoo US, Su YX, Zhang G. Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis. Clin Transl Med. 2025;15:e70261.","DOI":"10.1002\/ctm2.70261"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Di Martino JS, Akhter T, Bravo-Cordero JJ. Remodeling the ECM: Implications for metastasis and tumor dormancy. Cancers. 2021;13.","DOI":"10.3390\/cancers13194916"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Yuzhalin AE, Lim SY, Kutikhin AG, Gordon-Weeks AN. Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis. Biochim Biophys Acta Rev Cancer. 2018;1870:207-\u0080\u009328.","DOI":"10.1016\/j.bbcan.2018.09.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Pal SK, Nguyen CT, Morita KI, Miki Y, Kayamori K, Yamaguchi A, Sakamoto K. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma. J Oral Pathol Med. 2016;45:730-\u0080\u00939.","DOI":"10.1111\/jop.12430"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Patwardhan S, Mahadik P, Shetty O, Sen S. ECM stiffness-tuned exosomes drive breast cancer motility through thrombospondin-1. Biomaterials. 2021;279:121185.","DOI":"10.1016\/j.biomaterials.2021.121185"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Li Z, He T, Xing Z, Zhu J, Wu W, Su A. Inhibition of THBS1 axis contributes to the antitumor effect of PA-MSHA in anaplastic thyroid cancer. Exp Cell Res. 2025;444:114373.","DOI":"10.1016\/j.yexcr.2024.114373"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Wen Z, Zhang Y, Wang X, Wu YX, Mao J, Li QL, Gong SQ. THBS1-mediated degradation of collagen via the PI3K\/AKT pathway facilitates the metastasis and poor prognosis of OSCC. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms241713312"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Xiao M, Zhang J, Chen W, Chen W. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma. J Exp Clin Cancer Res. 2018;37:143.","DOI":"10.1186\/s13046-018-0815-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Zhang C, Fu J, Zhou Y. A review in research progress concerning m6A methylation and immunoregulation. Front Immunol. 2019;10:922.","DOI":"10.3389\/fimmu.2019.00922"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019\u0080\u0099 UTRs and near stop codons. Cell. 2012;149:1635-\u0080\u009346.","DOI":"10.1016\/j.cell.2012.05.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Zhou L, Li H, Cai H, Liu WH, Pan EJ, Yu DS, He S. Upregulation of IGF2BP2 promotes oral squamous cell carcinoma progression that ss related to cell proliferation, metastasis and tumor-infiltrating immune cells. Front Oncol. 2022;12:809589.","DOI":"10.3389\/fonc.2022.809589"}],"container-title":["Critical Reviews in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/5dda9d251a637819\/CRI-61135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T20:42:40Z","timestamp":1779828160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/2ff21abf44b19838,712794064b4c70af,5dda9d251a637819.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevimmunol.2026061135","relation":{},"ISSN":["1040-8401"],"issn-type":[{"value":"1040-8401","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}